FFCP PHASE1:Mm9::chr2:69252690..69252694,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |EntrezGene=NA | ||
|HGNC= | |HGNC= | ||
|MCL_coexpression_id=6 | |MCL_coexpression_id=6 | ||
|TSSclassifier=NA | |||
|UniProt=NA | |UniProt=NA | ||
|association_with_transcript=NA | |association_with_transcript=NA | ||
|cluster_id=chr2:69252690..69252694,- | |||
|description=CAGE_peak_at_chr2:69252690..69252694,- | |description=CAGE_peak_at_chr2:69252690..69252694,- | ||
|id=chr2:69252690..69252694,- | |id=chr2:69252690..69252694,- | ||
|ontology_enrichment_celltype=CL:0000355!4.12e-15!9 | |ontology_enrichment_celltype=CL:0000355!4.12e-15!9 | ||
|ontology_enrichment_celltype_v019_2=CL:0000355,4.12e-15,9 | |||
|ontology_enrichment_disease=DOID:0060100!1.75e-43!3;DOID:4045!1.75e-43!3;DOID:0050686!3.12e-22!6 | |ontology_enrichment_disease=DOID:0060100!1.75e-43!3;DOID:4045!1.75e-43!3;DOID:0050686!3.12e-22!6 | ||
|ontology_enrichment_disease_v019_2=DOID:0060100,1.75e-43,3;DOID:4045,1.75e-43,3;DOID:0050686,3.12e-22,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!4.12e-15!9;UBERON:0002036!4.12e-15!9;UBERON:0002385!4.12e-15!9;UBERON:0000486!4.12e-15!9;UBERON:0001015!4.12e-15!9;UBERON:0004290!4.12e-15!9;UBERON:0003082!4.12e-15!9;UBERON:0000383!1.11e-13!10;UBERON:0002329!1.65e-12!11;UBERON:0003077!1.65e-12!11;UBERON:0003059!1.65e-12!11;UBERON:0007282!1.65e-12!11;UBERON:0009618!1.65e-12!11;UBERON:0007285!1.65e-12!11;UBERON:0000914!2.36e-08!17 | |ontology_enrichment_uberon=UBERON:0001134!4.12e-15!9;UBERON:0002036!4.12e-15!9;UBERON:0002385!4.12e-15!9;UBERON:0000486!4.12e-15!9;UBERON:0001015!4.12e-15!9;UBERON:0004290!4.12e-15!9;UBERON:0003082!4.12e-15!9;UBERON:0000383!1.11e-13!10;UBERON:0002329!1.65e-12!11;UBERON:0003077!1.65e-12!11;UBERON:0003059!1.65e-12!11;UBERON:0007282!1.65e-12!11;UBERON:0009618!1.65e-12!11;UBERON:0007285!1.65e-12!11;UBERON:0000914!2.36e-08!17 | ||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,4.12e-15,9;UBERON:0002036,4.12e-15,9;UBERON:0002385,4.12e-15,9;UBERON:0000486,4.12e-15,9;UBERON:0007503,4.12e-15,9;UBERON:0001015,4.12e-15,9;UBERON:0002329,4.12e-15,9;UBERON:0003082,4.12e-15,9;UBERON:0003059,4.12e-15,9;UBERON:0007282,4.12e-15,9;UBERON:0004290,4.12e-15,9;UBERON:0009618,4.12e-15,9;UBERON:0000383,1.11e-13,10;UBERON:0007524,1.65e-12,11;UBERON:0003077,1.65e-12,11;UBERON:0007285,1.65e-12,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.34825304589526,1.5626706890476,1.57057123192139,14.7057872007754,6.14740936462601,2.91306211818692,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.34825304589526,1.5626706890476,1.57057123192139,14.7057872007754,6.14740936462601,2.91306211818692,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p@chr2:69252690..69252694,- | |short_description=p@chr2:69252690..69252694,- | ||
}} | }} |
Latest revision as of 09:21, 5 August 2015
Short description: | p@chr2:69252690..69252694, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr2:69252690..69252694, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 4.12e-15 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 4.12e-15 | 9 |
striated muscle tissue | 4.12e-15 | 9 |
muscle tissue | 4.12e-15 | 9 |
multilaminar epithelium | 4.12e-15 | 9 |
epithelial vesicle | 4.12e-15 | 9 |
musculature | 4.12e-15 | 9 |
somite | 4.12e-15 | 9 |
myotome | 4.12e-15 | 9 |
presomitic mesoderm | 4.12e-15 | 9 |
presumptive segmental plate | 4.12e-15 | 9 |
dermomyotome | 4.12e-15 | 9 |
trunk paraxial mesoderm | 4.12e-15 | 9 |
musculature of body | 1.11e-13 | 10 |
dense mesenchyme tissue | 1.65e-12 | 11 |
paraxial mesoderm | 1.65e-12 | 11 |
presumptive paraxial mesoderm | 1.65e-12 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 1.75e-43 | 3 |
muscle cancer | 1.75e-43 | 3 |
organ system cancer | 3.12e-22 | 6 |